Skip to main content

Table 5 Multivariate linear regression analysis with the variables related to the number of injections

From: Comparison of antiangiogenic agents (ranibizumab, aflibercept, bevacizumab and ziv-aflibercept) in the therapeutic response to the exudative form of age-related macular degeneration according to the treat-and-extend protocol- true head-to-head study

Variables

Non-standardized coefficient

Standardized coefficient

Assessment parameters

 

B

β

T

p

VIF

Drug

 Aflibercept

0

 Bevacizumab

0.852

0.318

3.600

 < 0.001

1.6

 Ranibizumab

1.309

0.493

5.608

 < 0.001

1.6

 Ziv-aflibercept

0.853

0.321

3.676

 < 0.001

1.6

 Baseline CRT

0.002

0.131

1.718

0.088

1.2

HRF

 No

0

 Yes

0.781

0.253

3.515

0.001

1.1

SHRM

 No

0

 Yes

0.520

0.212

2.734

0.007

1.2

  1. Notes: R2 = 38.9%, R2adjusted = 35.9%, R = 0.623, Durbin-Watson = 2.12